These findings underscore Irisin’s multifaceted role in neurocognitive regulation, highlighting its therapeutic potential in addressing conditions where synaptic plasticity deficits contribute to cognitive impairment (Figure 5). The gene discussed is FNDC5; the disease is Cognitive impairment.